Clinical trial No longer in our active list Interventional Ages 19 and up

Using super-oxidized solution for treating secondary peritonitis during emergency surgery

Official title: The Effect of Intraoperative Peritoneal Lavage With Super-Oxidized Solution on Surgical Site Infections and Mortality in Patients With Secondary Peritonitis: A Randomized Controlled Trial

Run by Insel Gruppe AG, University Hospital Bern · NCT05050253 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if using a special cleaning solution during emergency surgery can help patients with serious abdominal infections have fewer infections and better outcomes compared to a standard solution.

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment200 (estimated)
SponsorInsel Gruppe AG, University Hospital Bern
Academic / other
Locations1 site (Bern)
Trial IDNCT05050253 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 scheduled for emergency abdominal surgery due to secondary peritonitis from conditions like hollow-viscus perforation or abdominal abscess.

Probably not a fit

Patients with primary or tertiary peritonitis or those who are pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of peritoneal lavage with super-oxidized solution (SOS) compared to the standard Ringer's solution in patients undergoing emergency abdominal surgery for secondary peritonitis. Secondary peritonitis is a serious condition that can lead to high rates of morbidity and mortality due to surgical site infections and sepsis. The study aims to determine if SOS can reduce the incidence of surgical site infections and mortality in this patient population. Eligible patients will be randomized during surgery to receive either SOS or Ringer's solution as part of their treatment.

Why it matters

Potential benefit: If successful, this approach could significantly reduce surgical site infections and mortality rates in patients with secondary peritonitis.

How similar studies have gone: While the use of super-oxidized solutions is promising, this specific application in secondary peritonitis is novel and has not been extensively tested in previous studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Secondary peritonitis due to suspected hollow viscus perforation, anastomotic insufficiency, and/or abdominal abscess (including patients with the named abdominal emergencies as a complication after elective surgery)
* Scheduled emergency abdominal surgery by laparotomy with peritoneal lavage
* Age over 18 years
* Written informed consent

Exclusion Criteria

* Pregnancy (will be ruled out using beta-hCG testing in women of childbearing potential)
* Patients with primary or tertiary peritonitis

Where it's running

  • Inselspital, Bern University Hospital
    Bern, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.